Orestes Pasparakis

Dec 3, 2023 | lexblog.com | Orestes Pasparakis |Brian Daley |Allyson Whyte Nowak |Gunars Gaikis

This year marks the 30-year anniversary of the Patented Medicines (Notice of Compliance) Regulations (Regulations), introduced in 1993 to prevent patent infringement by linking the regulatory approval of generic or biosimilar drugs with the patent rights of innovators. Since their genesis, the Regulations have been the focal point of most of the pharmaceutical patent litigation in Canada. We have had the privilege of arguing many of the landmark cases on behalf of our clients.